Headquarters, Cobham, UK

Proteome Sciences’ executive management team, including business development, marketing and administrative functions, is located at its HQ in Cobham.

Research Facilities

Proteome Sciences employs more than 30 skilled scientists from across a broad range of complementary and diverse backgrounds essential to undertake high-output proteomics from two purpose built facilities in the UK and Germany. In addition to these, Proteome Sciences has benefited from extensive and longstanding collaborative research agreements with leading global academics and academic institutions in the field of proteomics in human disease, including University Cantonal Hospital Geneva, King’s College Hospital London, University of Michigan and Imperial College, London.

London

Proteome Sciences’ laboratory is located at the Institute of Psychiatry, King’s College London. It provides high sensitivity 2D gel electrophoresis and state-of-the-art mass spectrometry (MS) capabilities with a strong emphasis on the identification and analysis of post-translational modification of proteins, particularly protein phosphorylation, image analysis and bioinformatics. It has been actively involved in the development of rapid MS based assays.

Frankfurt

The Frankfurt facility was purpose built to accommodate the former proteomics division of Aventis Research and Technologies where PS Biomarker Services is based. The ISO 9001:2008 facility operates at the leading edge of high output proteomics (high throughput combined with high sensitivity). Through this facility, Proteome Sciences has novel, proprietary protein profiling technologies including TMT® (Tandem Mass Tags®) which offer simultaneous, timely and accurate relative quantitation of a large number of proteins for the discovery of novel targets or biomarkers.

All aspects of biomarker services, custom tagging, assay development and proteomics workflows can be outsourced through PS Biomarker Services.